Sai Life Sciences Ltd Financials
Company Logo

Sai Life Sciences Ltd Financial Statement

Sai Life Sciences Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Sai Life Sciences Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Total Revenue Annual1,418.68
Operating Expenses Annual1,132.07
Operating Profit Annual315.94
Interest Annual79.72
Depreciation98.80
Net Profit Annual95.23
Tax Annual33.77

Sai Life Sciences Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Cash Flow at the Beginning29.21
Cash Flow from Operations250.64
Cash Flow from Investing-190.05
Cash Flow from Financing-84.63
Cash Flow at the End5.17

Sai Life Sciences Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
PBDIT Margin (%)22.37
PBIT Margin (%)14.81
PBT Margin (%)14.63
Net PROFIT Margin (%)6.71
Return On Networth / Equity (%)9.90
Return On Networth /Employed (%)11.36
Return On Assets (%)5.17
Total Debt / Equity (X)0.90
Asset Turnover Ratio (%)0.77

Sai Life Sciences Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2024
Fixed Assets Annual1,073.75
Total Current Assets Annual951.17
Non Current Assets Annual1,288.75
Total Shareholders Funds Annual1,011.20
Total Assets Annual2,239.92

Sai Life Sciences Ltd Earning Calls

No Data Availabe

FAQS on Sai Life Sciences Ltd Financials

As of Feb 5, 2025, Sai Life Sciences Ltd has a market capitalization of - Cr. Value Research classifies it as a Micro-Cap company.
No, Sai Life Sciences Ltd is not debt-free with a debt-to-equity ratio of 0.86.
In FY 2024 , Sai Life Sciences Ltd recorded a total revenue of approximately 1,418.68 Cr marking a significant milestone in the company's financial performance.
Sai Life Sciences Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately NaN% and 0.3% annually, respectively..
Sai Life Sciences Ltd's current PE ratio is undefined.
Sai Life Sciences Ltd's ROCE averaged 6.9% from the FY ending March 2022 to 2024, with a median of 5.8%. It peaked at 11.1% in March 2024, reflecting strong capital efficiency over the period..
Sai Life Sciences Ltd's latest EBIT is Rs. 208.73 Cr, surpassing the average EBIT of Rs. 127.30 Cr over the 5 years..

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions